PreAnalytiX Introduces Novel Solution for Liquid Biopsy

PreAnalytiX GmbH, formed by QIAGEN N.V. and BD, has introduced the PAXgene Urine Liquid Biopsy Set for analyzing cell-free DNA in urine using various molecular testing technologies like qPCR, digital PCR, and NGS. QIAGEN will commercialize the new...

Takeda Secures Japanese Approval to manufacture Fruzaqla

Takeda has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW) to produce and sell Fruzaqla capsules 1mg/5mg (fruquintinib), an oral inhibitor of VEGFR-1, -2, and -3, for advanced or recurring colorectal cancer treatment...

AIIMS Delhi and Intuitive To set up Surgical Robotics Training Centre

AIIMS New Delhi and Intuitive, a global leader in minimally invasive technology and robotic-assisted surgery, signed an MoU to create a new training center for robotic-assisted surgery at AIIMS, New Delhi. The AIIMS da Vinci RAS training centre...

PCI Pharma Services Funnels Over $365 Million for Advanced Drug Delivery

PCI Pharma Services, a top CDMO specializing in complex biopharma therapies, is dedicating over $365 million to enhance infrastructure for assembling and packaging drug-device combination products with advanced drug delivery systems, particularly...

Innate Pharma gets US FDA Nod to begin phase 1 study of Nectin-4 ADC

Innate Pharma SA, a worldwide biotech firm in clinical stages advancing cancer immunotherapies, reported that the FDA has approved its IND application for a phase 1 clinical trial of IPH4502, a unique topoisomerase I inhibitor ADC targeting...

Antengene Bags Thailand FDA Approval To commercialize Xpovio

Antengene Corporation Limited, a top creative, internationally-operating biopharmaceutical company focused on finding, creating, and selling top-of-the-line medications for cancer, revealed that the Thailand Food and Drug Administration has given...

Govt Explores random testing of imported Medical Devices

The government is considering overseeing the quality of imported medical devices through a risk-based method in which random samples will be selected for quality testing, with entire shipments of critical diagnostic kits being...

CD Biopharma Receives US FDA Nod to commence phase I trial

Suzhou-based CD Biopharma, a fast-growing biotech company in the clinical stage, has been approved by the FDA for its CD-001 Investigational New Drug (IND) application, marking the start of a phase I human trial...

US FDA Nods AstraZeneca's Nasal Spray for Self Administration

AstraZeneca, a worldwide biopharmaceutical company focused on science, declared that FluMist is now the sole self-administered flu vaccine approved in the United States. FluMist, a nasal spray without needles, was authorized for...

PM Modi pledges $7.5 Mn to Quad Cancer Moonshot to battle cervical cancer

Prime Minister Narendra Modi declared assistance of USD 7.5 million in sampling kits, detection kits, and vaccines for nations combatting cervical cancer. Addressing the Cancer Moonshot event in Delaware, Modi stressed India's dedication to...

© 2024 India Pharma Outlook. All Rights Reserved.